Dose-Ranging Study of Ceftriaxone for Uncomplicated Gonorrhea in Men
AUTOR(ES)
Handsfield, H. Hunter
RESUMO
Uncomplicated gonorrhea in men was successfully treated with ceftriaxone in single intramuscular doses of 125 mg (15 patients), 250 mg (16 patients), or 500 mg (15 patients). All 45 pretreatment gonococcal isolates tested were inhibited by ≤0.016 μg of ceftriaxone per ml. Treatment was well tolerated and caused no toxicity.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=181809Documentos Relacionados
- Dose-Ranging Study of Ceftriaxone for Uncomplicated Gonorrhea in Men
- Dose-ranging study of CP-99,219 (trovafloxacin) for treatment of uncomplicated gonorrhea.
- Dose-ranging study of fleroxacin for treatment of uncomplicated Chlamydia trachomatis genital infections.
- Dose ranging study of cefpimizole (U-63196E) for treatment of uncomplicated gonorrhea in men.
- Adverse reactions in a dose-ranging study with a new long-acting fluoroquinolone, fleroxacin.
